Proceedings of the 12th International Conference on Thrombosis and Hemostasis Issues in Cancer, 2024
-
Welcome to the 12th ICTHIC!
Published: 16 May 20241208PDF: 126 -
Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape
Published: 29 February 20241175PDF: 164 -
Patient and public involvement in cancer-associated thrombosis research: necessary or glorified tokenism?
Published: 16 May 2024940PDF: 85 -
Endothelial cell dysfunction in cancer: a not-so-innocent bystander
Published: 16 May 2024783PDF: 78 -
Machine learning in cancer-associated thrombosis: hype or hope in untangling the clot
Published: 16 May 2024631PDF: 79 -
Cancer-associated ischemic stroke: current knowledge and future directions
Published: 16 May 2024463PDF: 129 -
Trends and updates on the epidemiology of cancer-associated thrombosis: a systematic review
Published: 16 May 2024358PDF: 106 -
Venous thromboembolism and mortality in patients with hematological malignancies
Published: 16 May 2024227PDF: 90 -
Cancer complicated by thrombosis and thrombocytopenia: still a therapeutic dilemma
Published: 16 May 2024224PDF: 70 -
Coagulome and tumor microenvironment: impact of oncogenes, cellular heterogeneity and extracellular vesicles
Published: 16 May 2024209PDF: 72 -
New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis
Published: 16 May 2024222PDF: 102 -
Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis
Published: 16 May 2024292PDF: 121 -
Identifying novel biomarkers using proteomics to predict cancer-associated thrombosis
Published: 16 May 2024352PDF: 141 -
Risk of recurrent venous thromboembolism in cancer patients after discontinuation of anticoagulant therapy
Published: 16 May 2024184PDF: 94